Pulse Biosciences, Inc. (PLSE) Q3 2026 Earnings Call Transcript
…
52,230$
-8,34%
Echtzeit-Aktienkurs Pulse Biosciences
Bid:
Ask:
Nachrichten zur Pulse Biosciences Aktie
Pulse Biosciences, Inc (PLSE) Reports Q3 Loss, Misses Revenue Estimates
Pulse Biosciences (PLSE) delivered earnings and revenue surprises of +8.57% and -21.00%, respectively, for the quarter ended September 2026. Do…
Pulse Biosciences: Präzisionsschläge im Nanosekundenbereich: Wie das Unternehmen die Medizin revolutioniert
Pulse Biosciences entwickelt mit der patentierten Nanosecond Pulsed Field Ablation ein hochpräzises, nicht-thermisches Verfahren, das krankhafte Zellen gezielt durch…
Pulse Biosciences: Klinische Fortschritte – jetzt rückt die Zulassung näher
Pulse Biosciences ist ein US-amerikanisches Medizintechnikunternehmen, das neuartige Verfahren zur gezielten Gewebeablation entwickelt. Im Mittelpunkt steht eine eigene Technologie, die…
Pulse Biosciences Aktie: Positive Überraschung
Kulmbach (www.aktiencheck.de) - Pulse Biosciences-Aktienanalyse von "Der Aktionär":Florian Söllner vom Anlegermagazin "Der Aktionär" nimmt im Interview mit "Der Aktionär TV"…
Pulse Biosciences targets early October enrollment completion for 164-patient NANOPULSE-AF study
…
Pulse Biosciences, Inc. (PLSE) Q2 2026 Earnings Call Transcript
…
Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Misses Revenue Estimates
Pulse Biosciences (PLSE) delivered earnings and revenue surprises of -16.13% and -38.00%, respectively, for the quarter ended June 2026. Do…
Heres Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to Buy
Does Pulse Biosciences, Inc (PLSE) have what it takes to be a top stock pick for momentum investors? Lets find…
Pulse Biosciences CEO Bought 15,000 Company Shares. Heres What That Means for Investors.
Pulse Biosciences, a developer of non-thermal bioelectric treatments, reported a notable insider buy amid recent stock price gains.…
Pulse Biosciences, Inc. (PLSE) Q1 2026 Earnings Call Transcript
…
PLSE Q4 2025 Earnings Transcript
Image source: The Motley Fool.DateThursday, Feb. 19, 2026, at 4:30 p.m. ETCall participantsChairman of the Board — Robert DugganCo-Chairman of…
Pulse Biosciences, Inc. (PLSE) Shareholder/Analyst Call - Slideshow
…
Pulse Biosciences, Inc. (PLSE) Shareholder/Analyst Call Transcript
…
Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates
Pulse Biosciences (PLSE) delivered earnings and revenue surprises of +18.75% and +5.60%, respectively, for the quarter ended December 2025. Do…
PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data
Pulse Biosciences shares late-breaking AF data showing up to 100% procedural success, fast procedures and low adverse events for nPulse.…
Pulse Biosciences stock rises after positive cardiac catheter study data By Investing.com
Pulse Biosciences stock rises after positive cardiac catheter study data…
Pulse Biosciences, Inc. (PLSE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
…
Pulse Biosciences drops 35% after InvestingPro’s "Overvalued" warning By Investing.com
Pulse Biosciences drops 35% after InvestingPro’s "Overvalued" warning…
PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor
Pulse Biosciences partners with MD Anderson to study its nPulse technology for treating benign and malignant thyroid tumors upon receiving…
Pulse Biosciences, Inc (PLSE) Reports Q3 Loss, Lags Revenue Estimates
Pulse Biosciences (PLSE) delivered earnings and revenue surprises of +6.45% and -82.80%, respectively, for the quarter ended September 2025. Do…
Pulse Biosciences: Some Key Questions Remain Unanswered
…
Pulse Biosciences reports wider Q4 loss, shares dip By Investing.com
Pulse Biosciences reports wider Q4 loss, shares dip…
Pulse Biosciences director Robert Duggan buys $972,343 in stock By Investing.com
Pulse Biosciences director Robert Duggan buys $972,343 in stock…
Pulse Biosciences Inc. (PLSE) Q2 2024 Earnings Call Transcript
…
Pulse Biosciences announces updated timing of rights offering for up to $60M
…
Earnings call: Pulse Biosciences reports progress with CellFX system By Investing.com
Earnings call: Pulse Biosciences reports progress with CellFX system…
Pulse Biosciences Inc (PLSE) Q1 2024 Earnings Call Transcript
…
Earnings call: Pulse Biosciences advances with FDA clearances and trials By Investing.com
Earnings call: Pulse Biosciences advances with FDA clearances and trials…
Pulse Biosciences Inc (PLSE) Q4 2023 Earnings Call Transcript
…
Pulse Biosciences files for $50M mixed securities shelf
…